Endo International Story

<div class='circular--portrait' style='background:#FF6600;color: #FFFAFA;font-size:4em;'>EI</div>
ENDP -- USA Stock  

USD 7.26  0.06  0.82%

Endo International Working Capital is very stable at the moment as compared to the past year. Endo International reported last year Working Capital of 1.13 Billion. As of 25th of December 2020, Asset Turnover is likely to grow to 0.30, while Invested Capital is likely to drop about 7.7 B. Today's short post will recap Endo International as your potential position. We will focus on the question of why insiders should continue to be confident in Endo International outlook.
Published over a month ago
View all stories for Endo International | View All Stories
Our recent forecast of Endo International (NASDAQ:ENDP)
Endo International is OVERVALUED at 5.96 per share with modest projections ahead. Over 82.0% of Endo International shares are held by institutions such as insurance companies. Institutional ownership of Endo International Plc refers to the amount of Endo International Plc equity owned by mutual funds, pension funds, insurance companies, investment firms, foundations, or other large entities that manage money on behalf of others. Check out our latest analysis of Endo International, including its current ownership diagnostics.
There are currently many different techniques concerning forecasting the market as a whole as well as predicting future values of individual securities such as Endo International Plc. Regardless of method or technology, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.

Predictive Modules for Endo International

Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Endo International's stock price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Endo International in the context of predictive analytics.
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Endo International. Your research has to be compared to or analyzed against Endo International's peers to derive any actionable benefits. When done correctly, Endo International's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Endo International Plc.

How important is Endo International's Liquidity

Endo International financial leverage refers to using borrowed capital as a funding source to finance Endo International Plc ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Endo International financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Please check the breakdown between Endo International's total debt and its cash.

What do experts say?

Stock analysis is a method for investors and traders to make buying and selling decisions. By studying and evaluating past and current data, investors and traders attempt to gain an edge in the markets by making informed decisions. It is good to see analyst projects for Endo International, but it might be worth checking our own buy vs. sell analysis

Breaking down Endo International Indicators

The recent price roll up of Endo International Plc could raise concerns from insiders as the firm it trading at a share price of 6.54 on 8,090,000 in volume. The company directors and management may have good odds in positioning the firm resources to exploit market volatility in January. The stock standard deviation of daily returns for 30 days investing horizon is currently 4.88. This high volatility is attributed to the latest market swings and not so good earnings reports for some of the Endo International partners.

Margin Breakdown

EBITDA Margin0.28
Gross Margin0.46
Profit Margin(0.16)

Can Endo International build up on the recent roll up?

Recent sortino ratio is at 0.21. Endo International Plc shows above-average downside volatility for the selected time horizon. We advise investors to inspect Endo International Plc further and ensure that all market timing and asset allocation strategies are consistent with the estimation of Endo International future alpha.

Our Conclusion on Endo International

Although many of the other players under the drug manufacturers?specialty & generic industry are still a bit expensive, Endo International may offer a potential longer-term growth to insiders. To conclude, as of the 25th of December 2020, our analysis shows that Endo International almost mirrors the market. The firm is overvalued and projects below average probability of distress for the next 2 years. Our actual 30 days recommendation on the firm is Strong Hold.

About Contributor

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Achuva Shats do not own shares of Endo International Plc. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com